{"id":20189,"date":"2023-12-20T10:13:31","date_gmt":"2023-12-20T15:13:31","guid":{"rendered":"https:\/\/www.emilysentourage.org\/?p=20189"},"modified":"2023-12-20T10:51:54","modified_gmt":"2023-12-20T15:51:54","slug":"nacfc-2023-key-takeaways-in-cystic-fibrosis-research","status":"publish","type":"post","link":"https:\/\/www.emilysentourage.org\/tr\/nacfc-2023-key-takeaways-in-cystic-fibrosis-research\/","title":{"rendered":"NACFC 2023: Kistik Fibrozis Ara\u015ft\u0131rmalar\u0131nda \u00d6nemli \u00c7\u0131kar\u0131mlar"},"content":{"rendered":"<p><i>Chandra Ghose, PhD, EE'nin Ba\u015f Bilim Sorumlusu taraf\u0131ndan<\/i><\/p>\n<p><span style=\"font-weight: 400;\">Kas\u0131m ay\u0131nda Phoenix, AZ'de d\u00fczenlenen Kuzey Amerika Kistik Fibrozis Konferans\u0131 (NACFC) 2023, k\u00fcresel kistik fibrozis (KF) toplulu\u011funu yenilenmi\u015f bir heyecan ve enerjiyle b\u0131rakt\u0131. Her y\u0131l merakla beklenen toplant\u0131, KF tedavisi i\u00e7in ara\u015ft\u0131rma, bak\u0131m ve ila\u00e7 geli\u015ftirmeyi ilerletmeye adanm\u0131\u015f ara\u015ft\u0131rmac\u0131lar, sa\u011fl\u0131k uzmanlar\u0131 ve savunucular\u0131n bir araya geldi\u011fi bir potad\u0131r. Bu y\u0131lki konferansta \u00e7\u0131\u011f\u0131r a\u00e7an ara\u015ft\u0131rmalar, yeni tedaviler ve KF bak\u0131m\u0131n\u0131n manzaras\u0131n\u0131 yeniden \u015fekillendirmeyi vaat eden i\u015fbirlik\u00e7i \u00e7abalar sergilendi.<\/span><\/p>\n<p><img fetchpriority=\"high\" decoding=\"async\" class=\"wp-image-20271 aligncenter\" src=\"https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Emily_s-Entrourage-Ntl-Cystic-Fibrosis-Conf-Rec-0-19-1-1024x683.jpg\" alt=\"Purple circular pins on a purple background with purple rhinestones. The buttons read 100% or Bust!\" width=\"640\" height=\"427\" srcset=\"https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Emily_s-Entrourage-Ntl-Cystic-Fibrosis-Conf-Rec-0-19-1-1024x683.jpg 1024w, https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Emily_s-Entrourage-Ntl-Cystic-Fibrosis-Conf-Rec-0-19-1-300x200.jpg 300w, https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Emily_s-Entrourage-Ntl-Cystic-Fibrosis-Conf-Rec-0-19-1-768x512.jpg 768w, https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Emily_s-Entrourage-Ntl-Cystic-Fibrosis-Conf-Rec-0-19-1-1536x1024.jpg 1536w, https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Emily_s-Entrourage-Ntl-Cystic-Fibrosis-Conf-Rec-0-19-1-2048x1365.jpg 2048w, https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Emily_s-Entrourage-Ntl-Cystic-Fibrosis-Conf-Rec-0-19-1-18x12.jpg 18w, https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Emily_s-Entrourage-Ntl-Cystic-Fibrosis-Conf-Rec-0-19-1-600x400.jpg 600w\" sizes=\"(max-width: 640px) 100vw, 640px\" \/><\/p>\n<p><span style=\"font-weight: 400;\">Bu y\u0131l ayr\u0131ca NACFC'de 130'dan fazla ara\u015ft\u0131rmac\u0131, klinisyen, end\u00fcstri temsilcisi ve topluluk \u00fcyesini bir araya getiren 6. Y\u0131ll\u0131k Emily's Entourage (EE) kokteyl resepsiyonumuza ev sahipli\u011fi yapt\u0131k. Etkinlikte KF ara\u015ft\u0131rmalar\u0131, ila\u00e7 geli\u015ftirme ve bak\u0131m alanlar\u0131nda yenilik\u00e7i de\u011fi\u015fimcileri \u00f6d\u00fcllendiren 2023 Trailblazer \u00d6d\u00fcl\u00fc, EE Bilimsel Dan\u0131\u015fma Kurulu \u00fcyesi Dr. Denis Hadjiliadis'e takdim edildi. Etkinlikte ayr\u0131ca, Emily'nin KF'sinin ileri evreleri g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda enfeksiyon \u00f6nlemleri nedeniyle sanal olarak kat\u0131lan EE kurucu ortaklar\u0131 Emily Kramer-Golinkoff ve Liza Kramer'in k\u0131sa konu\u015fmalar\u0131 da yer ald\u0131.\u00a0<\/span><\/p>\n<p><img decoding=\"async\" class=\"wp-image-20203 aligncenter\" src=\"https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Emily_s-Entrourage-Ntl-Cystic-Fibrosis-Conf-Rec-0-176-1-1024x819.jpg\" alt=\"\" width=\"640\" height=\"512\" srcset=\"https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Emily_s-Entrourage-Ntl-Cystic-Fibrosis-Conf-Rec-0-176-1-1024x819.jpg 1024w, https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Emily_s-Entrourage-Ntl-Cystic-Fibrosis-Conf-Rec-0-176-1-300x240.jpg 300w, https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Emily_s-Entrourage-Ntl-Cystic-Fibrosis-Conf-Rec-0-176-1-768x614.jpg 768w, https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Emily_s-Entrourage-Ntl-Cystic-Fibrosis-Conf-Rec-0-176-1-1536x1229.jpg 1536w, https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Emily_s-Entrourage-Ntl-Cystic-Fibrosis-Conf-Rec-0-176-1-2048x1638.jpg 2048w, https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Emily_s-Entrourage-Ntl-Cystic-Fibrosis-Conf-Rec-0-176-1-15x12.jpg 15w, https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Emily_s-Entrourage-Ntl-Cystic-Fibrosis-Conf-Rec-0-176-1-600x480.jpg 600w\" sizes=\"(max-width: 640px) 100vw, 640px\" \/><\/p>\n<p><span style=\"font-weight: 400;\">Resepsiyona ek olarak EE, misyonumuz ve \u00e7al\u0131\u015fmalar\u0131m\u0131z hakk\u0131nda daha fazla bilgi payla\u015fmak i\u00e7in \u00fcst \u00fcste ikinci y\u0131l sergi salonunda bir kioska sponsor oldu. Kioskumuzu ziyaret edenler pop\u00fcler \"100% or Bust\" rozetlerimizden ald\u0131lar! Etkinlik boyunca bu rozetleri takan insanlar\u0131 g\u00f6rmeye bay\u0131ld\u0131k.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">NACFC gelip ge\u00e7ti\u011fine g\u00f6re, konferanstan \u00e7\u0131kard\u0131\u011f\u0131m en ilgi \u00e7ekici bilimsel sonu\u00e7lardan baz\u0131lar\u0131n\u0131 payla\u015fmak istiyorum:<\/span><\/p>\n<h3><strong>Hassas T\u0131p Merkez Sahneye \u00c7\u0131k\u0131yor<\/strong><\/h3>\n<p><span style=\"font-weight: 400;\">NACFC 2023'\u00fcn sunumlar\u0131 ve genel oturumlar\u0131, KF i\u00e7in hassas t\u0131p alan\u0131nda at\u0131lan \u00f6nemli ad\u0131mlar\u0131 vurgulad\u0131. Akademik ve t\u0131bbi kurumlar\u0131n yan\u0131 s\u0131ra biyoteknoloji ve ila\u00e7 \u015firketlerinden ara\u015ft\u0131rmac\u0131lar, teratipleme ve organoid kullan\u0131m\u0131 gibi bireysel genetik varyasyonlar\u0131 ele almak i\u00e7in tasarlanm\u0131\u015f ki\u015fiselle\u015ftirilmi\u015f tedavi yakla\u015f\u0131mlar\u0131 hakk\u0131nda veriler sunarak, mevcut mod\u00fclat\u00f6r tedavilerinden yararlanamayan KF toplulu\u011funun son 10%'sine ula\u015fma potansiyeline sahip daha hedefli ve etkili tedavilerin \u00f6n\u00fcn\u00fc a\u00e7m\u0131\u015ft\u0131r. Gen d\u00fczenleme teknolojileri ve CRISPR-Cas9 uygulamalar\u0131nda artan ara\u015ft\u0131rma ve ila\u00e7 geli\u015ftirme \u00e7al\u0131\u015fmalar\u0131, KF ve di\u011fer genetik hastal\u0131klardan sorumlu altta yatan genetik kusurlar\u0131 d\u00fczeltme potansiyelini ortaya koymu\u015ftur.<\/span><\/p>\n<ul>\n<li><i><span style=\"font-weight: 400;\">\u0130lgili oturum: PL1- Herkes i\u00e7in Genetik Tedaviler: KF'de At\u0131l\u0131mlar i\u00e7in Hastal\u0131klar Aras\u0131 Bilgiden Yararlanma (Konu\u015fmac\u0131lar: Dr. Alexis Thompson ve Dr. Paul McCray)<\/span><\/i><\/li>\n<\/ul>\n<h3><b>CFTR Mod\u00fclat\u00f6rleri ve Di\u011fer Yeni Yakla\u015f\u0131mlardaki Geli\u015fmeler\u00a0<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">CFTR mod\u00fclat\u00f6rleri, KF'den sorumlu kusurlu CFTR proteinini hedef al\u0131r ve KF tedavisinde oyunun kurallar\u0131n\u0131 de\u011fi\u015ftiren bir unsur olmu\u015ftur. Konferansta en yeni nesil mod\u00fclat\u00f6rlerle ilgili g\u00fcncellemeler sunuldu ve bu mod\u00fclat\u00f6rler daha fazla etkinlik ve daha az yan etki g\u00f6sterdi. Bu geli\u015fmeler, nadir CFTR mutasyonlar\u0131na sahip olanlar da dahil olmak \u00fczere daha geni\u015f bir yelpazedeki KF'li bireyler i\u00e7in umut vaat etmektedir. <\/span><\/p>\n<ul>\n<li><span style=\"font-weight: 400;\"><em>\u0130lgili sunum:<\/em> <\/span><i><span style=\"font-weight: 400;\">W-22 Mod\u00fclat\u00f6r Tedavisine Uygun Olmayan KF'li ve N1303K Mutasyonlu Bireylerde ETI'yi De\u011ferlendirmek \u0130\u00e7in Yap\u0131lan A\u00e7\u0131k Etiketli \u00c7al\u0131\u015fman\u0131n Ara Sonu\u00e7lar\u0131. (Konu\u015fmac\u0131: Dr. George Solomon)<\/span><\/i><\/li>\n<\/ul>\n<h3><strong>CFTR Mod\u00fclat\u00f6rlerinin \u00d6tesinde Terap\u00f6tik Yakla\u015f\u0131mlar<\/strong><\/h3>\n<p><span style=\"font-weight: 400;\">CFTR mod\u00fclat\u00f6rlerinin \u00f6tesinde, cystetic Medicines'in \u00f6nc\u00fcl\u00fck etti\u011fi molek\u00fcler protez yakla\u015f\u0131m\u0131 gibi yeni yakla\u015f\u0131mlar klinik denemelere giriyor. \u015eirket duyurdu <\/span><a href=\"https:\/\/www.biospace.com\/article\/releases\/cystetic-medicines-doses-first-person-with-cystic-fibrosis-in-phase-1-trial-of-investigational-therapy-cm001-designed-to-form-ion-channels-to-help-restore-airway-function\/\"><span style=\"font-weight: 400;\">devam etmekte olan Faz 1 klinik \u00e7al\u0131\u015fmas\u0131nda KF'li ilk ki\u015fiye doz vermi\u015flerdi<\/span><span style=\"font-weight: 400;\"> (<\/span><span style=\"font-weight: 400;\">NCT05802264<\/span><\/a><span style=\"font-weight: 400;\">) ara\u015ft\u0131rma ama\u00e7l\u0131 inhale edilebilir k\u00fc\u00e7\u00fck molek\u00fcll\u00fc terapisi CM001'i tan\u0131tt\u0131. Cystetic Medicines'in arkas\u0131ndaki erken a\u015fama ara\u015ft\u0131rman\u0131n ba\u015flang\u0131\u00e7ta EE'den al\u0131nan bir hibe ile desteklendi\u011fini ve bu sayede ekibin \u015firketten ayr\u0131ld\u0131\u011f\u0131n\u0131 ve sonunda tedaviyi yeni bir tedaviye d\u00f6n\u00fc\u015ft\u00fcrmek i\u00e7in Deerfield Management'tan $32 milyon finansman sa\u011flad\u0131\u011f\u0131n\u0131 belirtmek gerekir.<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><em><span style=\"font-weight: 400;\">\u0130lgili sunum: <\/span><\/em><i><span style=\"font-weight: 400;\"><em>S-14: CM001,<\/em> CFTR i\u00e7in KF'li T\u00fcm \u0130nsanlara Fayda Sa\u011flayabilecek Klinik A\u015famal\u0131 Molek\u00fcler Protez. (Konu\u015fmac\u0131: Dr. Marty Burke)<\/span><\/i><\/li>\n<\/ul>\n<h3><strong>Yenilik\u00e7i Gen Terapisi Yakla\u015f\u0131mlar\u0131<\/strong><\/h3>\n<p><span style=\"font-weight: 400;\">NACFC'de, nadir veya anlams\u0131z mutasyonlar\u0131 olanlar da dahil olmak \u00fczere t\u00fcm KF pop\u00fclasyonu i\u00e7in potansiyel olarak \u00f6nemli bir etkiye sahip olabilecek gen terapisindeki heyecan verici geli\u015fmeler de a\u00e7\u0131kland\u0131. Ara\u015ft\u0131rmac\u0131lar, KF'den etkilenen h\u00fccrelere d\u00fczeltici genleri iletmek i\u00e7in viral vekt\u00f6rlerin ve yeni nanopartik\u00fcllerin kullan\u0131m\u0131n\u0131 ara\u015ft\u0131rman\u0131n umut verici sonu\u00e7lar\u0131n\u0131 payla\u015ft\u0131. Genetik mutasyonu CFTR geninin \"do\u011fru versiyonu\" ile de\u011fi\u015ftirerek, gen tedavileri KF'nin temel nedenini ele alarak \u00e7al\u0131\u015f\u0131r, b\u00f6ylece potansiyel olarak kal\u0131c\u0131 bir tedavi ve genetik mutasyondan ba\u011f\u0131ms\u0131z olarak KF'li t\u00fcm insanlara ula\u015fma potansiyeline sahip bir tedavi sunar.<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><i><span style=\"font-weight: 400;\">\u0130lgili sunumlar: S11.2 Hava Yollar\u0131na Viral Vekt\u00f6r \u0130letim Ara\u00e7lar\u0131 (Konu\u015fmac\u0131: Dr. Patrick Sinn)<\/span><\/i><\/li>\n<\/ul>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><i><span style=\"font-weight: 400;\">S11.4 Sistemik KF Gen Terapisinin \u00d6n\u00fcndeki Engelleri A\u015fmak i\u00e7in Polimerik Nanopartik\u00fcl Stratejileri. (Konu\u015fmac\u0131: Dr. Alexandra Piotrowski-Daspit)<\/span><\/i><\/li>\n<\/ul>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><i><span style=\"font-weight: 400;\">S11.3 Nanot\u0131plar ile Mukus Bariyerlerinin A\u015f\u0131lmas\u0131 (Konu\u015fmac\u0131: Dr. Justin Hanes)<\/span><\/i><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Bir ba\u015fka umut verici g\u00fcncelleme de \u015fuydu <\/span><a href=\"https:\/\/www.prnewswire.com\/news-releases\/splisense-successfully-completed-phase-1-study-of-spl84-rna-based-therapy-for-the-treatment-of-cystic-fibrosis-301918897.html#:~:text=In%20the%20Phase%201%20study,related%20adverse%20events%20were%20identified.\"><span style=\"font-weight: 400;\">SpliSense, SPL84'\u00fcn insanlarda ilk kez uygulanan Faz 1 klinik \u00e7al\u0131\u015fmas\u0131n\u0131 ba\u015far\u0131yla tamamlad\u0131<\/span><\/a><span style=\"font-weight: 400;\">3849+10 kilobaz (Kb) C-&gt;T splicing mutasyonu ta\u015f\u0131yan KF'li ki\u015filer i\u00e7in inhale antisens oligon\u00fckleotid (ASO) tedavisi. <\/span><span style=\"font-weight: 400;\">\u00a0<\/span><span style=\"font-weight: 400;\">SpliSense, yeni ASO pulmoner yakla\u015f\u0131m\u0131 sayesinde spesifik genetik mutasyonlar\u0131n \u00fcstesinden gelmeyi ve protein ifadesini ve i\u015flevini geri kazand\u0131rmay\u0131 veya azaltmay\u0131, b\u00f6ylece KF'nin temel nedenini hedeflemeyi ama\u00e7lamaktad\u0131r. Denemede SPL84'\u00fcn g\u00fcvenli oldu\u011fu ve iyi tolere edildi\u011fi g\u00f6r\u00fclm\u00fc\u015f, bu da SPL84'\u00fcn KF'li ki\u015filerin tedavisinde etkili bir ila\u00e7 olma potansiyelini ortaya koymu\u015ftur.<\/span><\/p>\n<ul>\n<li><em><span style=\"font-weight: 400;\">\u0130lgili Sunum: <\/span><\/em><i><span style=\"font-weight: 400;\">S-14: CM001, CFTR i\u00e7in KF'li T\u00fcm \u0130nsanlara Fayda Sa\u011flayabilecek Klinik A\u015famada Bir Molek\u00fcler Protez. (Konu\u015fmac\u0131: Dr. Batsheva Kerem)<\/span><\/i><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">NACFC, KF ara\u015ft\u0131rma ve tedavisinde yeni bir d\u00f6neme i\u015faret eden umut verici bir dizi yenilik, i\u015fbirli\u011fi ve at\u0131l\u0131m sergiledi. Hassas t\u0131p, CFTR mod\u00fclat\u00f6r ara\u015ft\u0131rmalar\u0131 ve gen bazl\u0131 terap\u00f6tik yakla\u015f\u0131mlarda at\u0131lan ad\u0131mlar, KF'li bireylerin ya\u015famlar\u0131n\u0131 d\u00f6n\u00fc\u015ft\u00fcrmeye y\u00f6nelik kolektif kararl\u0131l\u0131\u011f\u0131n alt\u0131n\u0131 \u00e7izmektedir. Konferans, ara\u015ft\u0131rmac\u0131lar, sa\u011fl\u0131k hizmeti sa\u011flay\u0131c\u0131lar\u0131 ve KF toplulu\u011fu aras\u0131ndaki ba\u015far\u0131l\u0131 i\u015fbirliklerini sergileyerek, KF'li hi\u00e7 kimsenin geride kalmamas\u0131n\u0131 ve hayat kurtar\u0131c\u0131 at\u0131l\u0131mlar\u0131n\u0131 beklememesini sa\u011flamak i\u00e7in birle\u015fik bir yakla\u015f\u0131m\u0131n \u00f6nemini vurgulam\u0131\u015ft\u0131r.<\/span><\/p>\n<p><img decoding=\"async\" class=\"wp-image-20568 aligncenter\" src=\"https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Emily_s-Entrourage-Ntl-Cystic-Fibrosis-Conf-Rec-0-136-1024x576.jpg\" alt=\"A crowd of professionals applauding after a presentation.\" width=\"640\" height=\"360\" srcset=\"https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Emily_s-Entrourage-Ntl-Cystic-Fibrosis-Conf-Rec-0-136-1024x576.jpg 1024w, https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Emily_s-Entrourage-Ntl-Cystic-Fibrosis-Conf-Rec-0-136-300x169.jpg 300w, https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Emily_s-Entrourage-Ntl-Cystic-Fibrosis-Conf-Rec-0-136-768x432.jpg 768w, https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Emily_s-Entrourage-Ntl-Cystic-Fibrosis-Conf-Rec-0-136-1536x864.jpg 1536w, https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Emily_s-Entrourage-Ntl-Cystic-Fibrosis-Conf-Rec-0-136-2048x1152.jpg 2048w, https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Emily_s-Entrourage-Ntl-Cystic-Fibrosis-Conf-Rec-0-136-18x10.jpg 18w, https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Emily_s-Entrourage-Ntl-Cystic-Fibrosis-Conf-Rec-0-136-600x338.jpg 600w\" sizes=\"(max-width: 640px) 100vw, 640px\" \/><\/p>\n<p><span style=\"font-weight: 400;\">NACFC'nin \u00f6nemli noktalar\u0131n\u0131 d\u00fc\u015f\u00fcn\u00fcrken, gelece\u011fin KF toplulu\u011fu i\u00e7in \u00e7\u0131\u011f\u0131r a\u00e7an tedaviler ve bu zorlu hastal\u0131ktan etkilenenler i\u00e7in iyile\u015ftirilmi\u015f ya\u015fam kalitesi potansiyeli ile muazzam bir umut vaat etti\u011fi a\u00e7\u0131kt\u0131r. Bu yolculu\u011fun bir par\u00e7as\u0131 olmaktan heyecan duyuyoruz ve vaatlerin ger\u00e7e\u011fe d\u00f6n\u00fc\u015fece\u011fi o g\u00fcn\u00fc sab\u0131rs\u0131zl\u0131kla bekliyoruz.<\/span><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-20275 aligncenter\" src=\"https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Team-1024x768.jpg\" alt=\"Emily's Entourage Team members in business attire smiling before a camera.\" width=\"640\" height=\"480\" srcset=\"https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Team-1024x768.jpg 1024w, https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Team-300x225.jpg 300w, https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Team-768x576.jpg 768w, https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Team-1536x1152.jpg 1536w, https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Team-2048x1536.jpg 2048w, https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Team-16x12.jpg 16w, https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Team-400x300.jpg 400w, https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Team-600x450.jpg 600w\" sizes=\"(max-width: 640px) 100vw, 640px\" \/><\/p>","protected":false},"excerpt":{"rendered":"<p>Chandra Ghose, PhD, EE'nin Bilimsel Ba\u015f Sorumlusu Kas\u0131m ay\u0131nda Phoenix, AZ'de d\u00fczenlenen Kuzey Amerika Kistik Fibrozis Konferans\u0131 (NACFC) 2023, k\u00fcresel kistik fibrozis (KF) toplulu\u011funu yenilenmi\u015f bir heyecan ve enerjiyle b\u0131rakt\u0131. Her y\u0131l merakla beklenen bu toplant\u0131, ara\u015ft\u0131rma, bak\u0131m ve ila\u00e7 teknolojilerini geli\u015ftirmeye adanm\u0131\u015f ara\u015ft\u0131rmac\u0131lar, sa\u011fl\u0131k uzmanlar\u0131 ve savunucular\u0131n bir araya geldi\u011fi bir pota... <\/p>\n<div class=\"clear\"><\/div>\n<p><a href=\"https:\/\/www.emilysentourage.org\/tr\/nacfc-2023-key-takeaways-in-cystic-fibrosis-research\/\" class=\"excerpt-read-more\">Daha fazla bilgi edinin<\/a><\/p>","protected":false},"author":1281,"featured_media":20278,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_seopress_robots_follow":"","_seopress_robots_imageindex":"","_seopress_robots_snippet":"","_seopress_robots_primary_cat":"none","_seopress_robots_breadcrumbs":"","_seopress_robots_freeze_modified_date":"","_seopress_robots_custom_modified_date":"","_seopress_robots_canonical":"","_seopress_social_fb_title":"","_seopress_social_fb_desc":"","_seopress_social_fb_img":"","_seopress_social_fb_img_attachment_id":0,"_seopress_social_fb_img_width":0,"_seopress_social_fb_img_height":0,"_seopress_social_twitter_title":"","_seopress_social_twitter_desc":"","_seopress_social_twitter_img":"","_seopress_social_twitter_img_attachment_id":0,"_seopress_social_twitter_img_width":0,"_seopress_social_twitter_img_height":0,"_seopress_redirections_value":"","_seopress_redirections_enabled":"","_seopress_redirections_enabled_regex":"","_seopress_redirections_logged_status":"both","_seopress_redirections_param":"","_seopress_redirections_type":301,"_seopress_analysis_target_kw":"","_monsterinsights_skip_tracking":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_hide_featured_image":false,"_jetpack_featured_image_duplicate_dismissed":0,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[1],"tags":[186],"class_list":["post-20189","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","tag-nacfc"],"acf":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/www.emilysentourage.org\/wp-content\/uploads\/Latte-e1703087144253.jpg","post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/www.emilysentourage.org\/tr\/wp-json\/wp\/v2\/posts\/20189","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.emilysentourage.org\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.emilysentourage.org\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.emilysentourage.org\/tr\/wp-json\/wp\/v2\/users\/1281"}],"replies":[{"embeddable":true,"href":"https:\/\/www.emilysentourage.org\/tr\/wp-json\/wp\/v2\/comments?post=20189"}],"version-history":[{"count":5,"href":"https:\/\/www.emilysentourage.org\/tr\/wp-json\/wp\/v2\/posts\/20189\/revisions"}],"predecessor-version":[{"id":20573,"href":"https:\/\/www.emilysentourage.org\/tr\/wp-json\/wp\/v2\/posts\/20189\/revisions\/20573"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.emilysentourage.org\/tr\/wp-json\/wp\/v2\/media\/20278"}],"wp:attachment":[{"href":"https:\/\/www.emilysentourage.org\/tr\/wp-json\/wp\/v2\/media?parent=20189"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.emilysentourage.org\/tr\/wp-json\/wp\/v2\/categories?post=20189"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.emilysentourage.org\/tr\/wp-json\/wp\/v2\/tags?post=20189"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}